ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 0367

Can Belonging to an AxSpA Patient Organization Be Associated with Benefits to Its Members? Results from the European Map of Axial Spondyloarthritis (EMAS)

Marco Garrido-Cumbrera1, Souzi Makri2, Denis Poddubnyy3, Christine Bundy4, Laura Christen5, Sergio Sanz-Gomez6, José Correa-Fernández6, Raj Mahapatra7, Carlos Jesús Delgado-Domínguez6 and Victoria Navarro-Compán8, 1Health & Territory Research (HTR), University of Seville, Sevilla, Spain, 2Cyprus League Against Rheumatism (CYPLAR), Limassol, Cyprus, 3Department of Rheumatology, Charité – Universitätsmedizin, Berlin, Germany, 4Cardiff University, Cardiff, Wales, United Kingdom, 5Novartis Pharma AG, Basel, Switzerland, 6Health & Territory Research (HTR), Universidad de Sevilla, Seville, Spain, 7Axial Spondyloarthritis International Federation (ASIF), London, United Kingdom, 8Rheumatology service, Hospital Universitario La Paz-IdiPaz, Madrid, Spain

Meeting: ACR Convergence 2021

Keywords: Ankylosing spondylitis (AS), education, patient, Patient reported outcomes, physical activity, spondyloarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 6, 2021

Session Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster I: Clinical Aspects of Axial Spondyloarthritis (0357–0386)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Patient organizations (POs) provide education and support services aimed to improve the quality of life of axSpA patients. This analysis aims to identify factors associated with PO membership among European axSpA patients.

Methods: Data from 2,846 unselected patients participating in EMAS, an online survey (2017-2018) across 13 European countries, were collected. Membership of patient organizations was assessed by the following item: “Are you a member of any Spondylitis Support Group or Association? (Yes/No)”. Differences in sociodemographics, patient-reported outcomes [BASDAI (0-10), spinal stiffness (3-12), and mental health through GHQ-12 (0-12)], employment, lifestyle habits, comorbidities, and treatments between PO members/non-members were assessed through Mann-Whitney and Pearson’s χ2 tests. Univariable and multivariable binary logistic regression were used to identify variables possibly explaining PO membership.

Results: 1,654 patients were included. Mean age was 43.0 (±12.3) years, 59.6% were female, 46.8% had a university degree, and 66.5% were married. 1,107 patients (38.9%) were members of a PO. Compared to non-members, members were more frequently male (41.5% vs 36.9%, p=0.014), married (73.3% vs 64.5%, p< 0.001), more overweight/obese (55.6% vs 50.0%, p=0.003), physically active (86.4% vs 78.9%, p< 0.001), had relatives affected by axSpA (48.1% vs 33.1%), longer disease duration (21.0 vs 14.8 years, p< 0.001), better mental health (4.7 vs 5.1, p=0.036), longer diagnostic delay (8.6 vs 6.7, p< 0.001), and were more likely to have ever taken biologics (49.1% vs 37.0%, p< 0.001). In the multivariable logistic regression analysis, the variables associated with PO membership were having ever taken biologics (OR= 1.87), being physically active (OR= 1.43), having relatives affected by axSpA (OR= 1.34), and disease duration (OR= 1.03).

Conclusion: PO members were more likely to have advanced disease, as suggested by the disease duration. Greater experience with biologics among PO members could be attributed to higher disease severity but also to having access to lay-level information on treatment options. Notably, members were also more likely to engage in physical activity, a complementary treatment strongly promoted by POs and recommended by ASAS/EULAR. Engaging patients earlier and throughout their disease journey is likely to improve long-term health and quality of life.

Table 1. Bivariate analysis between members and non-members of POs (N= 2,846 unless specified)

Table 2. Logistic regression analysis for variables associated with PO membership (N=1,654)


Disclosures: M. Garrido-Cumbrera, None; S. Makri, None; D. Poddubnyy, AbbVie, 2, 5, 6, Eli Lilly and Company, 2, 5, 6, MSD, 2, 5, 6, Novartis, 2, 5, 6, Pfizer, 2, 5, 6, UCB, 2, 6, BMS, 2, 6, Roche, 2, 6; C. Bundy, Abbvie, 2, Celgene, 2, Janssen, 2, Lilly, 2, Novartis, 2, Pfizer, 2; L. Christen, Novartis, 3; S. Sanz-Gomez, None; J. Correa-Fernández, None; R. Mahapatra, None; C. Delgado-Domínguez, None; V. Navarro-Compán, Abbvie, 5, Lilly, 5, Novartis, 5, Pfizer, 5, UCB, 5, Janssen, 5.

To cite this abstract in AMA style:

Garrido-Cumbrera M, Makri S, Poddubnyy D, Bundy C, Christen L, Sanz-Gomez S, Correa-Fernández J, Mahapatra R, Delgado-Domínguez C, Navarro-Compán V. Can Belonging to an AxSpA Patient Organization Be Associated with Benefits to Its Members? Results from the European Map of Axial Spondyloarthritis (EMAS) [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/can-belonging-to-an-axspa-patient-organization-be-associated-with-benefits-to-its-members-results-from-the-european-map-of-axial-spondyloarthritis-emas/. Accessed January 30, 2023.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/can-belonging-to-an-axspa-patient-organization-be-associated-with-benefits-to-its-members-results-from-the-european-map-of-axial-spondyloarthritis-emas/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences